Jack Nathan Medical Corp.
JNHMF
$0.00
$0.000.00%
OTC PK
07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
---|---|---|---|---|---|
Revenue | 6.08M | 6.10M | 6.13M | -822.60K | -1.03M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 6.08M | 6.10M | 6.13M | -822.60K | -1.03M |
Cost of Revenue | 787.20K | 863.90K | 940.50K | -18.90K | 143.80K |
Gross Profit | 5.29M | 5.24M | 5.19M | -803.80K | -1.17M |
SG&A Expenses | 6.30M | 6.47M | 6.68M | 1.07M | 528.20K |
Depreciation & Amortization | 160.00K | 172.60K | 194.80K | -100.20K | -178.80K |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 7.25M | 7.51M | 7.81M | 951.60K | 492.70K |
Operating Income | -1.17M | -1.40M | -1.68M | -1.77M | -1.52M |
Income Before Tax | -1.16M | -1.58M | -1.77M | -790.50K | -987.70K |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -1.17 | -1.59 | -1.78 | -0.19 | -0.39 |
Earnings from Discontinued Operations | 6.95M | 6.61M | 7.03M | -158.60K | -158.60K |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 5.78M | 5.02M | 5.25M | -4.28M | -4.48M |
EBIT | -1.17M | -1.40M | -1.68M | -1.77M | -1.52M |
EBITDA | -910.10K | -973.40K | -1.08M | -1.05M | -875.10K |
EPS Basic | 0.07 | 0.06 | 0.06 | -0.05 | -0.05 |
Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
EPS Diluted | 0.07 | 0.06 | 0.06 | -0.05 | -0.05 |
Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Average Basic Shares Outstanding | 348.40M | 346.03M | 343.66M | 342.10M | 340.49M |
Average Diluted Shares Outstanding | 358.07M | 358.69M | 356.32M | 354.42M | 347.81M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |